Abstract
AbstractComputer simulations were used to evaluate the truncated area under the plasma level-time curves (AUC.) as indicators of the bioequivalence between test and reference products. Plasma concentrations were simulated from one and two compartment open models using first order absorption rate constants (Ka) and bioavailability (F) ranging respectively from 45 to 200% and 60 to 140% of the reference values. The pharmacokinetic parameters were selected to cover a wide range of disposition rate constants (0.01-0.79 hr.−1). The area under the blood level-time curves was calculated using the trapezoidal rule at each time point (t) according to a conventional sampling regimen. The extent of absorption (AUC.inf) was calculated, using integrals of the general blood equations. The ratios of AUC.: test to reference and AUCL to AUC.were determined. For most simulations, the ratios changed very little between the end of the absorption period, the last time point and the time infinity. AUC, was not a good parameter...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Clinical Research Practices and Drug Regulatory Affairs
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.